Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Chemotherapy and Autotransplantation for Newly Diagnosed Anaplastic Oligodendroglioma
NCT00588523Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2002
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide, busulfan, thiotepa in anaplastic oligodendroglioma (AO), anaplastic mixed glioma (AOA), sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 2002; status: completed.
02
Drugs
temozolomidebusulfanthiotepa
03
Conditions
anaplastic oligodendroglioma (AO)anaplastic mixed glioma (AOA)
Beyond the preview
Go deeper on NCT00588523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00588523.